IVISense MMP 645 FAST Fluorescent Probe (MMPSense)
IVISense MMP 645 FAST Fluorescent Probe (MMPSense)
Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.
Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.
For research use only. Not for use in diagnostic procedures.
| Feature | Specification |
|---|---|
| Unit Size | 1 Vial (10 doses) |
Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.
Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.
For research use only. Not for use in diagnostic procedures.
IVISense MMP 645 FAST Fluorescent Probe (MMPSense)
IVISense MMP 645 FAST Fluorescent Probe (MMPSense)
Product information
Overview
IVISense MMP 645 FAST is excited by 649 nm excitation light, and emits at 666 nm. MMP 645 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture termed F.A.S.T. (Fluorescent Activatable Sensor Technology), that allows for an earlier optimal imaging window of 6-24 hours after injection, facilitating detection of early MMP activity changes, for example in acute models of inflammation or stroke. Including IVISense MMP 645 FAST in careful experimental design allows for multiplexing with other channels and/or imaging times, and so can be paired with other probes to achieve maximum efficiency and flexibility in imaging.
Specifications
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Activatable
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Therapeutic Area |
Arthritis
Atherosclerosis
Inflammation
Oncology/Cancer
|
| Unit Size |
1 Vial (10 doses)
|
| Wave Length |
645 nm
|
Resources
Are you looking for resources, click on the resource type to explore further.
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...
Epifluorescence (2D) imaging of superficially implanted mouse tumor xenograft models offers a fast and simple method for assessing...
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
言語English国EU
-
言語English国United States
-
Lot numberANYLot dateSeptember 6, 2023名前
How can we help you?
We are here to answer your questions.
